Contractility and ischemic response of hearts from transgenic mice with altered sarcolemmal K(ATP) channels.
The functional significance of ATP-sensitive K(+) (K(ATP)) channels is controversial. In the present study, transgenic mice expressing a mutant Kir6.2, with reduced ATP sensitivity, were used to examine the role of sarcolemmal K(ATP) in normal cardiac function and after an ischemic or metabolic challenge. We found left ventricular developed pressure (LVDP) was 15-20% higher in hearts from transgenics in the absence of cardiac hypertrophy. beta-Adrenergic stimulation caused a positive inotropic response from nontransgenic hearts that was not observed in transgenic hearts. Decreasing extracellular Ca(2+) decreased LVDP in hearts from nontransgenics but not in those from transgenics. These data suggest an increase in intracellular [Ca(2+)] in transgenic hearts. Additional studies have demonstrated hearts from nontransgenics and transgenics have a similar postischemic LVDP. However, ischemic preconditioning does not improve postischemic recovery in transgenics. Transgenic hearts also demonstrate a poor recovery after metabolic inhibition. These data are consistent with the hypothesis that sarcolemmal K(ATP) channels are required for development of normal myocardial function, and perturbations of K(ATP) channels lead to hearts that respond poorly to ischemic or metabolic challenges.
Department of Physiology, University of Tennessee School of Medicine, 894 Union Avenue, Memphis, TN 38163, USA.
R
R
Rajashree
J C
JC
Koster
K P
KP
Markova
C G
CG
Nichols
P A
PA
Hofmann
D000255:Adenosine Triphosphate / Q000502:physiology*; D000818:Animals; D003847:Deoxyglucose / Q000378:metabolism; D066298:In Vitro Techniques; D019157:Ischemic Preconditioning, Myocardial; D051379:Mice; D008822:Mice, Transgenic / Q000235:genetics; D009200:Myocardial Contraction; D017202:Myocardial Ischemia / Q000503:physiopathology*; D015428:Myocardial Reperfusion Injury / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D015221:Potassium Channels / Q000378:metabolism*; D011312:Pressure; D012016:Reference Values; D012508:Sarcolemma / Q000378:metabolism*; D012966:Sodium Cyanide / Q000494:pharmacology; D016277:Ventricular Function, Left / Q000187:drug effects
D015221:Potassium Channels; D000255:Adenosine Triphosphate; D003847:Deoxyglucose; D012966:Sodium Cyanide